Table 2.

GO and KEGG Pathway Enrichment Analyses of DEGs in Rhabdomyosarcoma Samples.

Term	Description	Count in gene set	P-value
GO:0007049	Cell cycle	52	9.31E-09
GO:0006936	Muscle contraction	44	1.79E-31
GO:0003012	Muscle system process	44	1.3E-29
GO:0007010	Cytoskeleton organization	43	2.01E-12
GO:0007517	Muscle organ development	36	9.77E-18
GO:0043232	Intracellular non-membrane-bounded organelle	134	1.09E-14
GO:0043228	Non-membrane-bounded organelle	134	1.09E-14
GO:0005856	Cytoskeleton	104	2.03E-22
GO:0044430	Cytoskeletal part	79	4.19E-19
GO:0005739	Mitochondrion	55	1.32E-05
GO:0000166	Nucleotide binding	77	0.04579
GO:0008092	Cytoskeletal protein binding	69	4.11E-28
GO:0017076	Purine nucleotide binding	69	0.02485
GO:0032555	Purine ribonucleotide binding	63	0.07086
GO:0032553	Ribonucleotide binding	63	0.07086
hsa04260	Cardiac muscle contraction	19	3.74E-11
hsa05414	Dilated cardiomyopathy	17	3.82E-08
hsa05410	Hypertrophic cardiomyopathy	16	8.51-08
hsa05010	Alzheimer’s disease	14	0.00279
hsa04530	Tight junction	13	0.00152

GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed genes